Trial Profile
A Randomized, Double Blind , Placebo Controlled Trial to Compare the Effect of Tiotropium [Spiriva] Inhalation Capsules on Exercise Tolerance in Patients With COPD [chronic obstructive pulmonary disease] Participating in 8 Weeks of Pulmonary Rehabilitation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Dec 2017
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 20 Dec 2007 Status changed from in progress to completed.
- 10 Aug 2006 Status change
- 30 Oct 2005 New trial record.